33 min listen
Ted Yednock Part 2: Response to the Emergence of Progressive Multifocal Leukoencephalopathy
FromiBiology Videos
Ted Yednock Part 2: Response to the Emergence of Progressive Multifocal Leukoencephalopathy
FromiBiology Videos
ratings:
Length:
29 minutes
Released:
Dec 26, 2020
Format:
Podcast episode
Description
Just a few months after Tysabri was approved for MS treatment, two patients developed progressive multifocal leukoencephalopathy (PML), a fatal or seriously debilitating disease. In his second talk, Yednock describes the response of medical and regulatory groups and researchers to this discovery and its impact on the treatment of MS patients with Natalizumab/Tysabri.
Released:
Dec 26, 2020
Format:
Podcast episode
Titles in the series (92)
Prescott Woodruff & Joseph Arron Part 1: Molecular Phenotyping of Asthma: Asthma is a heterogeneous disease with varying degrees of airway inflammation and variable response to treatment with inhaled corticosteroids. Woodruff and Arron describe experiments to develop a biomarker to detect asthma subtypes and determine which ... by iBiology Videos